Heart Valve Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Regent China Post-Market Clinical Follow-up Study
Conditions: Valvular Heart Disease; Aortic Valve Disease Intervention: Device: Abbott Mechanical Heart Valve (MHV) Regent™ Sponsor: Abbott Medical Devices Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2022 Category: Research Source Type: clinical trials